Σύγκριση μεθόδων

	Δείκτης Ενεργότητας Νόσου του Crohn	Δείκτης Harvey-Bradshaw
Πεδίο	Γαστρεντερολογία	Γαστρεντερολογία
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1976	1980
Δημιουργός	Best, W. R., Becktel, J. M., Singleton, J. W., and Kern, F.	R. F. Harvey and J. M. Bradshaw
Τύπος	Clinician-rated	Clinician-rated
Θεμελιώδης πηγή	Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976). Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology, 70(3), 439–444.	Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet, 315(8167), 514.
Εναλλακτικές ονομασίες	CDAI	HBI
Συναφείς	4	5
Σύνοψη	The Crohn's Disease Activity Index (CDAI) is a comprehensive, weighted index for assessing disease activity in Crohn's disease. Developed in 1976 by Best and colleagues for the National Cooperative Crohn's Disease Study, the CDAI integrates eight clinical and laboratory variables into a single score ranging from <150 (remission) to >450 (severe activity). Although more complex than symptom-based tools, the CDAI captures the multidimensional nature of Crohn's disease and remains the reference standard for severe disease assessment.	The Harvey-Bradshaw Index (HBI) is a simple, clinician-administered tool for assessing disease activity in Crohn's disease. Developed in 1980, it measures five clinical parameters including abdominal pain, stool frequency, and extraintestinal manifestations. The HBI is widely used in clinical practice and research for monitoring disease progression and treatment response.